Cost-effectiveness analysis of enhancements to angioplasty for infrainguinal arterial disease

British Journal of Surgery

Volumn 100, Issue 9, 2013, Pages 1180-1188

  Kearns, B C ^a   Michaels, J A ^a   Stevenson, M D ^a   Thomas, S M ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AMPUTATION; ARTICLE; COST BENEFIT ANALYSIS; DRUG ELUTING STENT; ECONOMICS; EVALUATION; HUMAN; INGUINAL CANAL; INTERMITTENT CLAUDICATION; LEG; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; QUALITY ADJUSTED LIFE YEAR; STATISTICS; STENT; VASCULARIZATION;

AGED; AMPUTATION; ANGIOPLASTY, BALLOON; COST-BENEFIT ANALYSIS; DRUG-ELUTING STENTS; HUMANS; INGUINAL CANAL; INTERMITTENT CLAUDICATION; LEG; QUALITY-ADJUSTED LIFE YEARS; STENTS;

EID: 84880119627     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9195     Document Type: Article

References (26)

1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, et al.; TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease. Int Angiol 2007; 26: 81-157.
2. Hertzer NR,. The natural history of peripheral vascular disease. Implications for its management. Circulation 1991; 83 (Suppl): I12-I19.
3. Office for National Statistics. Population Estimates for UK, England and Wales, Scotland and Northern Ireland, Mid-2010. http://www.ons.gov.uk/ons/ taxonomy/index.html?nscl=Population [accessed 1 September 2012].
4. Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clement D, Collet JP, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases. Eur Heart J 2011; 32: 2851-2906.
5. Vascular Society of Great Britain and Ireland (VSGBI). The Provision of Services for Patients with Vascular Disease. VSGBI: Edinburgh, 2012.
6. National Institute of Health Research Health Technology Assessment Programme. Details of HTA Project, 2012. http://www.hta.ac.uk/project/2324.asp [accessed 1 September 2012].
7. National Institute for Health and Clinical Excellence. Guide to the Methods of Technology Appraisal. http://www.nice.org.uk/media/B52/A7/ TAMethodsGuideUpdatedJune2008.pdf [accessed 1 September 2012].
8. Bergqvist D, Troëng J, Elfström B, Hedberg K, Ljungström G, Norgren L, et al. Auditing surgical outcome: ten years with The Swedish Vascular Registry-Swedvasc. The Steering Committee of Swedvasc. Eur J Surg 1998; 164: 3-32.
9. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992; 326: 381-386.
10. Hunink MG, Wong JB, Donaldson MC, Meyerovitz MF, Harrington DP,. Patency results of percutaneous and surgical revascularization for femoropopliteal arterial disease. Med Decis Making 1994; 14: 71-81.
11. Axisa B, Fishwick G, Bolia A, Thompson MM, London NJM, Bell PRF, et al. Complications following peripheral angioplasty. Ann R Coll Surg Engl 2002; 84: 39-42.
12. Hunink MG, Wong JB, Donaldson MC, Meyerovitz MF, de Vries J, Harrington DP,. Revascularization for femoropopliteal disease. A decision and cost-effectiveness analysis. JAMA 1995; 274: 165-171.
13. National Institute for Health and Clinical Excellence. Clinical Guidelines: Lower Limb Peripheral Arterial Disease (CG147). http://guidance. nice.org.uk/CG147 [accessed 1 September 2012].
14. de Vries SO, Visser K, de Vries JA, Wong JB, Donaldson MC, Hunink MG,. Intermittent claudication: cost-effectiveness of revascularization versus exercise therapy. Radiology 2002; 222: 25-36.
15. Sculpher M, Michaels J, McKenna M, Minor J,. A cost-utility analysis of laser-assisted angioplasty for peripheral arterial occlusions. Int J Technol Assess 1996; 12: 104-125.
16. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, et al.; BASIL Trial Participants. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005; 366: 1925-1934.
17. Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FG, Gillespie I, et al.; BASIL Trial Participants. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: analysis of amputation free and overall survival by treatment received. J Vasc Surg 2010; 51 (Suppl): 18S-31S.
18. Ara R, Brazier JE,. Populating an economic model with health state utility values: moving toward better practice. Value in Health 2010; 13: 509-518.
19. Department of Health. 2010-11 Reference Costs Publication. http://www.dh.gov.uk/health/2011/11/reference-costs/ [accessed 1 September 2012].
20. Cejna M, Thurnher S, Illiasch H, Horvath W, Waldenberger P, Hornik K, et al. PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study. J Vasc Interv Radiol 2001; 12: 23-31.
21. Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, et al.; Zilver PTX Investigators. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv 2011; 4: 495-504.
22. SimpsonEL, Michaels JA, Thomas SM, Cantrell AJ,. Systematic review and meta-analysis of additional technologies to enhance angioplasty for infra-inguinal peripheral arterial occlusive disease: a systematic review and meta-analysis. Br J Surg 2013; 100: 1128-1137.
23. Saxon RR, Dake MD, Volgelzang RL, Katzen BT, Becker GJ,. Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease. J Vasc Interv Radiol 2008; 19: 823-832.
24. Jahnke T, Mueller-Huelsbeck S, Charalambous N, Trentmann J, Jamili A, Huemme TH, et al. Prospective, randomized single-center trial to compare cryoplasty versus conventional angioplasty in the popliteal artery: midterm results of the COLD study. J Vasc Interv Radiol 2010; 21: 186-194.
25. Spiliopoulos S, Katsanos K, Karnabatidis D, Diamantopoulos A, Kagadis GC, Christeas N, et al. Cryoplasty versus conventional balloon angioplasty of the femoropopliteal artery in diabetic patients: long-term results from a prospective randomized single-center controlled trial. Cardiovasc Intervent Radiol 2010; 33: 929-938.
26. Krankenberg H, Schlüter M, Steinkamp HJ, Burgelin K, Scheinert D, Schulte KL, et al,. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation 2007; 116: 285-292.